LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2
Clinical trial NCT01763866 · COMPLETED
Trial details
- NCT number
- NCT01763866
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-15
- Primary completion
- 2013-11-12
- Enrollment
- 2067
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.